key: cord-0743837-g1zry5z5 authors: Jia, Xiaoming; Jneid, Hani title: Practice patterns for patients with ST‐elevation myocardial infarction during the early phase of the COVID‐19 pandemic—Valuable lessons learned date: 2021-08-09 journal: Catheter Cardiovasc Interv DOI: 10.1002/ccd.29843 sha: 9b9103ed6b8ead727e9530e53914f245e23448d3 doc_id: 743837 cord_uid: g1zry5z5 During the early phase of the COVID‐19 pandemic in the United States, there was a significant reduction in cardiac catheterization lab activations and numbers of PPCIs for STEMI as well as an increase in door‐to‐balloon time. The decrease in STEMI volume is likely multifaceted involving factors at the patient and health system levels. Longitudinal data on STEMI care beyond the early phase of the pandemic is needed to better understand how different health systems have been adapting to the ongoing pandemic. The decrease in PPCI rates and increase in door-to-balloon times observed in the present study from the United States were similar to trends observed in high-volume PCI centers in Europe. 2 A metaanalysis pooling multiple studies from Europe and Asia suggests that the time from symptom onset to first medical contact after STEMI did not change after the start of the pandemic. Importantly, that study found that there was no significant increase in-hospital mortality among patients presenting with STEMI. 3 The cause of the decrease in STEMI activations is likely multifaceted involving patients' fear of exposure to COVID-19 and reluctance to go to the hospital combined with hospital oversaturation, shortage of supplies and staff, and in the hardest-hit areas the tremendous strain placed on emergency medical services to bring sick patients to medical centers. Meanwhile, the increase in door-to-balloon times likely reflected the change in STEMI protocols adopted by hospitals to accommodate COVID-19 patients, including infection screening and donning of personal protective equipment. 4 Furthermore, it was recognized early on that COVID-19 infection often resulted in myocardial injury leading to troponin elevations and in some cases also ST-segment elevation on the electrocardiogram in the absence of obstruction to major epicardial coronary arteries. 5 Thus, in more equivocal cases, utilization of noninvasive imaging (i.e., point of care echocardiography or cardiac computer tomography) prior to cath lab activation may have also contributed to an increase in the door-to-balloon time. Impact of COVID-19 pandemic on STEMI care: an expanded analysis from the United States Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis Management of acute myocardial infarction during the COVID-19 pandemic: a consensus statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned